2022/01/06 by Han‐Chow E. Koh, Chao Cao, Bettina Mittendorfer · 1 citation
Medicine · #Adipose Tissue and Metabolism #Diabetes, Cardiovascular Risks, and Lipoproteins #Adipokines, Inflammation, and Metabolic Diseases
paper · pdf · doi:10.3390/ijms23020596
openalex publication_date 2022/01/06 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Plasma insulin clearance is an important determinant of plasma insulin concentration. In this review, we provide an overview of the factors that regulate insulin removal from plasma and discuss the interrelationships among plasma insulin clearance, excess adiposity, insulin sensitivity, and type 2 diabetes (T2D). We conclude with the perspective that the commonly observed lower insulin clearance rate in people with obesity, compared with lean people, is not a compensatory response to insulin resistance but occurs because insulin sensitivity and insulin clearance are mechanistically, directly linked. Furthermore, insulin clearance decreases postprandially because of the marked increase in insulin delivery to tissues that clear insulin. The commonly observed high postprandial insulin clearance in people with obesity and T2D likely results from the relatively low insulin secretion rate, not an impaired adaptation of tissues that clear insulin.